作者
Chengyuan Liang, Nan Hui, Yuzhi Liu, Guaiping Qiao, Juan Li, Lei Tian, Xingke Ju, Minyi Jia, Hong Liu, Wenqiang Cao, Pengcheng Yu, Han Li, Xiaodong Ren
发表日期
2021/5/1
来源
Phytomedicine Plus
卷号
1
期号
2
页码范围
100027
出版商
Elsevier
简介
Background
In December 2019, a novel coronavirus, SARS-CoV-2 caused a series of acute atypical respiratory diseases worldwide. However, there is still a lack of drugs with clear curative effects, and the clinical trial research of vaccines has not been completely finished.
Purpose
LH capsules are approved TCM patent medicine that are widely used for the treatment of respiratory tract infectious diseases caused by colds and flu. On April 12, 2020, LH capsules and granules were officially repurposed by the China Food and Drug Administration (CFDA) for patients with mild COVID-19 based on their safety and efficacy demonstrated through multicentre, randomized, controlled clinical trials. We hope to conduct a comprehensive review of it through modern pharmacy methods, and try to explain its possible mechanism.
Methods
Using the full names of LH capsules Lianhuaqingwen, Lianhua Qingwen andSARS-COV-2 …
引用总数
学术搜索中的文章